4.8 Article

Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy

Journal

NANO LETTERS
Volume 21, Issue 5, Pages 2216-2223

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.nanolett.0c05028

Keywords

polyprodrug; combination chemotherapy; mitoxantrone; curcumin

Funding

  1. National Natural Science Foundation of China [51873072, 52073101, 81571665, 81971574]
  2. Science and Technology Program of Guangzhou [202002030268, 201904010422, 201804020060]
  3. Guangdong Provincial Pearl River Talents Program [2019QN01Y088]
  4. Natural Science Foundation of Guangdong Province in China [2018A030313282]
  5. Outstanding Scholar Program of Bioland Laboratory (Guangzhou Regener-ative Medicine and Health Guangdong Laboratory) [2018GZR110102001]

Ask authors/readers for more resources

An innovative dual-drug delivery system was designed in this study to achieve precise drug release ratios and generate synergistic anticancer effects.
The codelivery of drugs at specific optimal ratios to cancer cells is vital for combination chemotherapy. However, most of the current strategies are unable to coordinate the loading and release of drug combinations to acquire precise and controllable synergistic ratios. In this work, we designed an innovative dual-drug backboned and reduction-sensitive polyprodrug PEG-P-(MTO-ss-CUR) containing the anticancer drugs mitoxantrone (MTO) and curcumin (CUR) at an optimal synergistic ratio to reverse drug resistance. Due to synchronous drug activation and polymer backbone degradation, drug release at the predefined ratio with a synergistic anticancer effect was demonstrated by in vitro and in vivo experiments. Therefore, the dual-drug delivery system developed in this work provides a novel and efficient strategy for combination chemotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Radiology, Nuclear Medicine & Medical Imaging

Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase

Wen-jie Tang, Qing-cong Kong, Zi-xuan Cheng, Yun-shi Liang, Zhe Jin, Lei-xin Chen, Wen-ke Hu, Ying-ying Liang, Xin-hua Wei, Yuan Guo, Xin-qing Jiang

Summary: This study investigated the effect of imaging features at different DCE-MRI phases on predicting TIL levels in breast cancer. Results showed that image features from delayed phase MRI had the best predictive performance, and the fusion multi-sequence radiomics model and combined radiomics-based clinical model performed the best in predicting TILs.

EUROPEAN RADIOLOGY (2022)

Article Engineering, Biomedical

A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis

Shiwei Luo, Di Ma, Ruili Wei, Wang Yao, Xinrui Pang, Ye Wang, Xiangdong Xu, Xinhua Wei, Yuan Guo, Xinqing Jiang, Youyong Yuan, Ruimeng Yang

Summary: Ferroptosis is a promising non-apoptotic regulated cell death form for cancer treatment. However, the efficacy of ferroptosis is limited by high glutathione levels and insufficient hydrogen peroxide levels in tumors. In this study, a theranostic nanoplatform was designed to enhance ferroptosis in the tumor microenvironment by releasing active components, and it was also used for tumor-specific magnetic resonance imaging, exhibiting high specificity and efficacy.

ACTA BIOMATERIALIA (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Fuhrman nuclear grade prediction of clear cell renal cell carcinoma: influence of volume of interest delineation strategies on machine learning-based dynamic enhanced CT radiomics analysis

Shiwei Luo, Ruili Wei, Songlin Lu, Shengsheng Lai, Jialiang Wu, Zhe Wu, Xinrui Pang, Xinhua Wei, Xinqing Jiang, Xin Zhen, Ruimeng Yang

Summary: This study investigates the impact of different volume of interest (VOI) delineation strategies on machine learning-based predictive models for discrimination between low and high nuclear grade clear cell renal cell carcinoma (ccRCC) on dynamic contrast-enhanced CT. The findings suggest that radiomics features extracted from the unenhanced phase (UP) and excretory phase (EP) outperform features from other phases in differentiating high vs low nuclear grade ccRCC. Shape features and first-order statistics features showed superior discrimination ability.

EUROPEAN RADIOLOGY (2022)

Article Materials Science, Biomaterials

Nitric oxide nano-prodrug platform with synchronous glutathione depletion and hypoxia relief for enhanced photodynamic cancer therapy

Wang Yao, Kewei Wang, Yuan Guo, Ruili Wei, Shiwei Luo, Wenjie Tang, Nianhua Wang, Chutong He, Xinhua Wei, Ruimeng Yang, Youyong Yuan, Xinqing Jiang

Summary: A multifunctional nanoplatform was designed to enhance the efficacy of photodynamic therapy (PDT) by using a GSH-responsive nitric oxide (NO) nano-prodrug that simultaneously depletes GSH and relieves hypoxia in tumors.

BIOMATERIALS ADVANCES (2022)

Article Oncology

A Computed Tomography Nomogram for Assessing the Malignancy Risk of Focal Liver Lesions in Patients With Cirrhosis: A Preliminary Study

Hongzhen Wu, Zihua Wang, Yingying Liang, Caihong Tan, Xinhua Wei, Wanli Zhang, Ruimeng Yang, Lei Mo, Xinqing Jiang

Summary: A nomogram incorporating clinical risk factors, blood indicators, and CT imaging findings was developed to predict the nature of FLLs in cirrhotic livers. The nomogram showed excellent discrimination and calibration for malignancy risk prediction, and it may aid in making FLLs treatment decisions.

FRONTIERS IN ONCOLOGY (2022)

Article Pharmacology & Pharmacy

Folic Acid-Decorated β-Cyclodextrin-Based Poly(ε-caprolactone)-dextran Star Polymer with Disulfide Bond-Linker as Theranostic Nanoparticle for Tumor-Targeted MRI and Chemotherapy

Huikang Yang, Nianhua Wang, Ruimeng Yang, Liming Zhang, Xinqing Jiang

Summary: Folic acid-decorated reduction-sensitive star polymeric nanoparticles were synthesized and used for tumor-targeted MRI and chemotherapy. The nanoparticles efficiently delivered drugs and superparamagnetic iron oxide particles into tumor cells through folate receptor-mediated endocytosis and disulfide bond cleavage.

PHARMACEUTICS (2022)

Article Chemistry, Multidisciplinary

Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy

Yangyang Zhao, Yansong Dong, Shuhan Yang, Yalan Tu, Chengbo Wang, Jun Li, Youyong Yuan, Zhexiong Lian

Summary: In this study, CAR-T cells were engineered with HAase and alpha-PDL1 to improve their therapeutic effects on solid tumors. The modified CAR-T cells showed enhanced penetration into solid tumors, stronger antitumor activity, and no significant systemic side effects in animal models.

ACS CENTRAL SCIENCE (2022)

Article Engineering, Biomedical

Self-amplified chain-shattering cinnamaldehyde-based poly(thioacetal) boosts cancer chemo-immunotherapy

Qingyu Zong, Jisi Li, Xuan Xiao, Xiaojiao Du, Youyong Yuan

Summary: This study presents a self-amplified chain-shattering polymer that selectively activates stimuli-responsive polymers in the tumor microenvironment for intelligent cancer therapy. The polymer is designed with ROS-responsive thioacetal and ROS-generating cinnamaldehyde, achieving self-amplified chain shattering for polymer degradation. The polymer can be modified with anticancer drug doxorubicin to amplify oxidative stress and immunogenic cell death of tumor cells, enhancing the effect of chemo-immunotherapy.

ACTA BIOMATERIALIA (2022)

Article Materials Science, Biomaterials

A helical oncolytic polypeptide with potent membranolytic activity for cancer therapy

Xue Hu, Jie Li, Yuhao Zhang, Menghua Xiong, Houbing Zhang, Youyong Yuan

Summary: In this study, a cationic helical oncolytic polypeptide (OLPP) with potent membranolytic activity was synthesized using ring-opening polymerization and thiol-ene reaction. The OLPP showed resistance to protease, high cytotoxicity to cancer cells, and induced cancer cell necrosis by lysing the cancer cell membrane independent of intracellular pathways. Intra-tumoral injection of the OLPP effectively suppressed tumor growth in mice, suggesting its potential as an oncolytic chemotherapeutic for cancer therapy.

BIOMATERIALS SCIENCE (2023)

Article Engineering, Biomedical

Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy

Ye Liu, Maolin Jiang, Zhongyi Zhao, Nianhua Wang, Kewei Wang, Youyong Yuan

Summary: This study presents a smart nanoplatform CF@NDOX, which significantly up-regulates the expression of tumor-associated enzyme NQO1 through cyclic amplification of intracellular ROS, leading to efficient activation of the prodrug DOX and enhanced chemo-immunotherapy.

ACTA BIOMATERIALIA (2023)

Article Chemistry, Multidisciplinary

Dual stimulus-triggered bioorthogonal nanosystem for spatiotemporally controlled prodrug activation and near-infrared fluorescence imaging

Zhongyi Zhao, Qingyu Zong, Jun Li, Maolin Jiang, Kewei Wang, Youyong Yuan

Summary: In this study, we combined low pH and cathepsin B dual-stimulus-triggered delivery carriers with a bioorthogonal reaction-activated prodrug to achieve regulated activation of the prodrug. The bioorthogonal reaction provides a feasible method for precise tumor therapy and imaging, by activating the prodrug and fluorescent probe.

CHEMICAL COMMUNICATIONS (2023)

Article Chemistry, Multidisciplinary

A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy

Jun Li, Qingyu Zong, Zhongyi Zhao, Youyong Yuan

Summary: In this study, a tumor-specific self-accelerating prodrug activation nanosystem was developed. It contains a self-amplifying degradable polyprodrug PEG-TA-CA-DOX and encapsulated fluorescent prodrug BCyNH2, which has a reactive oxygen species dual-cycle amplification effect. Furthermore, the activated CyNH2 serves as a therapeutic agent with the potential to synergistically improve chemotherapy.

CHEMICAL COMMUNICATIONS (2023)

Article Chemistry, Multidisciplinary

AIEgens Cross-linked Iron Oxide Nanoparticles Synchronously Amplify Bimodal Imaging Signals in Situ by Tumor Acidity-Mediated Click Reaction

Yansong Dong, Ye Liu, Yalan Tu, Youyong Yuan, Jun Wang

Summary: In this study, an activatable dual-modal probe is proposed that enhances near-infrared fluorescence intensity and magnetic resonance contrast through a tumor acidity-mediated click reaction. The probe was successfully activated and cross-linked in a mouse breast tumor, prolonging its retention and enhancing the bimodal signals.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Chemistry, Multidisciplinary

Perivascular nanocarrier aggregation as a drug reservoir augments tumor drug delivery and treatment efficacy

Yansong Dong, Yalan Tu, Ye Liu, Maolin Jiang, Emil Bulatov, Youyong Yuan, Jun Wang

Summary: Anticancer nanomedicines can effectively aggregate around tumor blood vessels to create drug reservoirs for targeted drug delivery, improving therapeutic efficiency for cancer treatment.

NANO TODAY (2023)

No Data Available